BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker Corporation (NYSE:SYK) on Tuesday, setting a price target of $275, which is approximately 3.66% above the present share price of $265.28.
Zimmerman expects Stryker Corporation to post earnings per share (EPS) of $1.51 for the second quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Moderate Buy rating of shares in Stryker, with an average price target of $263.33.
The analysts price targets range from a high of $275 to a low of $250.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $4.26 billion and a net profit of $770 million. The company's market cap is $99.83 billion.
According to TipRanks.com, BTIG analyst Ryan Zimmerman is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 41.0% and a 68.88% success rate.
Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.